Results 211 to 220 of about 57,167 (281)
Potential utility of the fatty liver index as a predictor of erectile dysfunction and its severity. [PDF]
Ates HA +4 more
europepmc +1 more source
ABSTRACT Body mass index (BMI) on its own is a poor diagnostic and staging tool for obesity because it does not measure health status. The newly published Lancet Clinical Obesity Criteria (LCOC) for defining clinical obesity distinguish preclinical and clinical obesity based on organ or tissue dysfunction.
Tak Ying Louise Ko +3 more
wiley +1 more source
Efficacy and Safety of Phosphodiesterase-5 Inhibitors for Erectile Dysfunction in Schizophrenia: A Systematic Review and Meta-Analysis. [PDF]
Saito A, Sakuma K, Iwata N, Kishi T.
europepmc +1 more source
ABSTRACT Introduction Anabolic‐androgenic steroid (AAS) use is rising in Australia; however, discontinuation poses challenges due to withdrawal symptoms and a lack of clinical guidance. Therefore, the aim of this study was to explore online discourses around post‐cycle therapy (PCT), including perceived health risks, benefits and barriers, among people
Jonathan Easton +4 more
wiley +1 more source
A narrative review of the distribution and role of multipotent fibroblasts in penile tissue: implications for regenerative medicine and erectile dysfunction. [PDF]
Fridayana FR, Rho BY, Yin GN, Ryu JK.
europepmc +1 more source
Central nervous system involvement in cardiac amyloidosis: Redefining the heart‐brain axis
Central nervous system involvement in cardiac amyloidosis. Amyloidosis is a systemic disease that can directly affect the central nervous system. Furthermore, the amyloid cardiomyopathy can indirectly affect the central nervous system by inducing systemic hypoperfusion and increasing the risk of acute ischaemic stroke.
Domenico Mario Giamundo +3 more
wiley +1 more source
The Relationship Between the Time Until Penile Fracture Repair and Post-Operative Erectile Dysfunction. [PDF]
Bıçak Y, Dede O.
europepmc +1 more source

